A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder

Clinical trial NCT00965419 · TERMINATED

Trial details

NCT number: NCT00965419
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2009-09-01
Primary completion: 2015-07-01
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.